Skip to main content
main-content

Virtual EASD Annual Meeting 2020 coverage

Get the latest news and expert commentary now.

Editors' pick

09-26-2020 | EASD 2020 | Conference coverage | News

Cardioprotective measures neglected in young-onset type 2 diabetes

People with type 2 diabetes, especially young people, do not receive treatment for hypertension and dyslipidemia in a timely manner, even when they have high cardiovascular risk, study results show.

09-25-2020 | EASD 2020 | Conference coverage | Article

DAPA-CKD trial: Renal benefits of SGLT2 inhibition in people with and without diabetes

DAPA-CKD lead investigator Hiddo Heerspink discusses the positive outcomes of dapagliflozin treatment in people with kidney disease both with and without type 2 diabetes (8:13).

09-25-2020 | EASD 2020 | Conference coverage | News

Intermittent very-low-calorie diet could be easier to stomach for people with diabetes

The pilot MIDDAS study suggests that a 2-day per week very-low-calorie diet could be a viable alternative to a continuous diet for people with type 2 diabetes who struggle with this approach.

Why psychosocial care matters

Clinical experts from the fields of diabetes and psychology address the issues in a new series of interviews.

  • » This content has been endorsed by the PSAD, EASD and ACBRD.

Latest from across the site

09-26-2020 | EASD 2020 | Conference coverage | News

C-peptide a reliable guide to residual beta cells across ages, diabetes durations

Levels of circulating C-peptide in people with type 1 diabetes reflect the numbers of remaining beta cells across different ages at diagnosis and durations of disease, confirm UK researchers.

09-26-2020 | EASD 2020 | Conference coverage | News

COVID-19: Study evaluates telemedicine use by people with type 1 diabetes

A questionnaire study provides insights into the use and perception of telemedicine among people with type 1 diabetes during the COVID-19 pandemic.

09-26-2020 | EASD 2020 | Conference coverage | News

Cardioprotective measures neglected in young-onset type 2 diabetes

People with type 2 diabetes, especially young people, do not receive treatment for hypertension and dyslipidemia in a timely manner, even when they have high cardiovascular risk, study results show.

09-25-2020 | EASD 2020 | Conference coverage | News

Ethnicity, obesity linked to risk for early-onset type 2 diabetes

The development of type 2 diabetes at a young age disproportionately affects people of South Asian and African–Caribbean ethnicity, and obesity is associated with early-onset diabetes in all ethnic groups, indicates research presented at the virtual 56th EASD Annual Meeting.

09-25-2020 | EASD 2020 | Conference coverage | Article

DAPA-CKD trial: Renal benefits of SGLT2 inhibition in people with and without diabetes

DAPA-CKD lead investigator Hiddo Heerspink discusses the positive outcomes of dapagliflozin treatment in people with kidney disease both with and without type 2 diabetes (8:13).

09-25-2020 | EASD 2020 | Conference coverage | Article

EMPEROR-Reduced: Empagliflozin benefits in HF patients irrespective of diabetes

Lead investigator Milton Packer compares the EMPEROR-Reduced results with those of the DAPA-HF trial, and talks about how SGLT2 inhibitors will impact the treatment of heart failure (6:27).

Flash glucose monitoring technology

Browse new slide sets summarizing the latest results from real-world studies.

Meet our Editorial Board

New Content Item Meet our Advisory Board

Latest from us on Twitter

Trending this week

Image Credits